Literature DB >> 27827466

What is better/reliable, mitosis counting or Ki67/MIB1 staining?

Mark Kriegsmann1, Arne Warth1.   

Abstract

Entities:  

Year:  2016        PMID： 27827466      PMCID： PMC5099505          DOI： 10.21037/tlcr.2016.10.11

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  21 in total

1.  Factors affecting immunoreactivity in long-term storage of formalin-fixed paraffin-embedded tissue sections.

Authors:  Federica Grillo; Simona Pigozzi; Paola Ceriolo; Paola Calamaro; Roberto Fiocca; Luca Mastracci
Journal:  Histochem Cell Biol       Date:  2015-03-11       Impact factor: 4.304

2.  Assessment of interobserver variability in mitotic figure counting in different histological grades of oral squamous cell carcinoma.

Authors:  K Shailaja Yadav; Sudhir Gonuguntla; Kranti Kiran Reddy Ealla; Surekha Reddy Velidandla; C R Charan Reddy; M D Prasanna; Sanjay Reddy Bommu
Journal:  J Contemp Dent Pract       Date:  2012-05-01

3.  Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.

Authors:  Hiroyoshi Tsubochi; Nobuyuki Sato; Misae Hiyama; Mitsuomi Kaimori; Shunsuke Endo; Yasunori Sohara; Tadashi Imai
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

4.  A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.

Authors:  Kyuichi Kadota; Kei Suzuki; Stefan S Kachala; Emily C Zabor; Camelia S Sima; Andre L Moreira; Akihiko Yoshizawa; Gregory J Riely; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  Mod Pathol       Date:  2012-04-13       Impact factor: 7.842

5.  Mitosis trumps T stage and proposed international association for the study of lung cancer/american thoracic society/european respiratory society classification for prognostic value in resected stage 1 lung adenocarcinoma.

Authors:  Edwina Elizabeth Duhig; Andrew Dettrick; David Burleigh Godbolt; John Pauli; Anthony van Zwieten; Aaron Richard Hansen; Ian Anthony Yang; Kwun Meng Fong; Belinda Edith Clarke; Rayleen Veronica Bowman
Journal:  J Thorac Oncol       Date:  2015-04       Impact factor: 15.609

6.  Pathologist interobserver variability of histologic features in childhood brain tumors: results from the CCG-945 study.

Authors:  Floyd H Gilles; C Jane Tavaré; Laurence E Becker; Peter C Burger; Allan J Yates; Ian F Pollack; Jonathan L Finlay
Journal:  Pediatr Dev Pathol       Date:  2007-09-25

7.  14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts.

Authors:  Christian Jackisch; Nadia Harbeck; Jens Huober; Gunter von Minckwitz; Bernd Gerber; Hans-Heinrich Kreipe; Cornelia Liedtke; Norbert Marschner; Volker Möbus; Heike Scheithauer; Andreas Schneeweiss; Christoph Thomssen; Sibylle Loibl; Matthias W Beckmann; Jens-Uwe Blohmer; Serban-Dan Costa; Thomas Decker; Ingo Diel; Peter A Fasching; Tanja Fehm; Wolfgang Janni; Hans-Joachim Lück; Nicolai Maass; Anton Scharl; Michael Untch
Journal:  Breast Care (Basel)       Date:  2015-06-23       Impact factor: 2.860

8.  Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.

Authors:  Takashi Eguchi; Kyuichi Kadota; Jamie Chaft; Brent Evans; John Kidd; Kay See Tan; Joe Dycoco; Kathryn Kolquist; Thaylon Davis; Stephanie A Hamilton; Kraig Yager; Joshua T Jones; William D Travis; David R Jones; Anne-Renee Hartman; Prasad S Adusumilli
Journal:  Oncotarget       Date:  2016-06-07

9.  Evaluation of the interobserver agreement in the number of mitotic figures of breast carcinoma as simulation of quality monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol.

Authors:  H Tsuda; F Akiyama; M Kurosumi; G Sakamoto; K Yamashiro; T Oyama; T Hasebe; K Kameyama; T Hasegawa; S Umemura; K Honma; T Ozawa; K Sasaki; H Morino; S Ohsumi
Journal:  Jpn J Cancer Res       Date:  2000-04

10.  Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis.

Authors:  B Martin; M Paesmans; C Mascaux; T Berghmans; P Lothaire; A-P Meert; J-J Lafitte; J-P Sculier
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640
View more
  3 in total

1.  Metastatic uterine tumor resembling ovarian sex cord tumor: A case report and review of the literature.

Authors:  Michelle L Kuznicki; Sharon E Robertson; Ardeshir Hakam; Mian M Shahzad
Journal:  Gynecol Oncol Rep       Date:  2017-09-29

2.  Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma.

Authors:  Robert A Belderbos; Alexander P W M Maat; Sara J Baart; Eva V E Madsen; Ad J J C Bogers; Robin Cornelissen; Joachim G J V Aerts; Edris A F Mahtab; Jan H von der Thüsen
Journal:  JTO Clin Res Rep       Date:  2021-02-15

3.  Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients.

Authors:  Sarabjot Pabla; Jeffrey M Conroy; Mary K Nesline; Sean T Glenn; Antonios Papanicolau-Sengos; Blake Burgher; Jacob Hagen; Vincent Giamo; Jonathan Andreas; Felicia L Lenzo; Wang Yirong; Grace K Dy; Edwin Yau; Amy Early; Hongbin Chen; Wiam Bshara; Katherine G Madden; Keisuke Shirai; Konstantin Dragnev; Laura J Tafe; Daniele Marin; Jason Zhu; Jeff Clarke; Matthew Labriola; Shannon McCall; Tian Zhang; Matthew Zibelman; Pooja Ghatalia; Isabel Araujo-Fernandez; Arun Singavi; Ben George; Andrew Craig MacKinnon; Jonathan Thompson; Rajbir Singh; Robin Jacob; Lynn Dressler; Mark Steciuk; Oliver Binns; Deepa Kasuganti; Neel Shah; Marc Ernstoff; Kunle Odunsi; Razelle Kurzrock; Mark Gardner; Lorenzo Galluzzi; Carl Morrison
Journal:  J Immunother Cancer       Date:  2019-02-01       Impact factor: 13.751
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.